SCHEMBL29348245

SCHEMBL29348245

CC(C)N1CCOC(F)(F)C1=O

nearest known ligand 0.30

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 1/20 0.30
▸ OPRD1 P41143 1/20 0.30
▸ OPRK1 P41145 1/20 0.30
▸ OPRL1 P41146 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18650812 0.78 LMNA (0.30) —
SCHEMBL18766418 0.76 OPRM1 (0.30) OPRM1OPRD1OPRK1OPRL1
SCHEMBL13003396 0.75 — —
SCHEMBL29348251 0.68 PER2 (0.35) OPRM1OPRD1OPRK1OPRL1
SCHEMBL1106523 0.66 — —
SCHEMBL22916075 0.65 — —
SCHEMBL12026643 0.64 CYP2D6 (0.39) OPRM1OPRD1OPRK1OPRL1
SCHEMBL13216615 0.64 RARA (0.35) OPRM1OPRD1OPRK1OPRL1
SCHEMBL23325924 0.63 CYP2D6 (0.35) OPRM1OPRD1OPRK1OPRL1
SCHEMBL25041233 0.63 SMN1; SMN2 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151547-A1 TARGETED DEGRADATION OF VAV1 MONTE ROSA THERAPEUTICS, INC. (US) 2024-07-18 — — WO disclosed
Send feedback